Emerson Electric Valuation
Is EMR * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of EMR * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: EMR * (MX$2042) is trading below our estimate of fair value (MX$2312.16)
Significantly Below Fair Value: EMR * is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for EMR *?
Other financial metrics that can be useful for relative valuation.
What is EMR *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$62.30b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 4.5x |
Enterprise Value/EBITDA | 17.5x |
PEG Ratio | 2.1x |
Price to Earnings Ratio vs Peers
How does EMR *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 29.8x | ||
GCARSO A1 Grupo Carso. de | 20.3x | 16.6% | Mex$275.9b |
AME AMETEK | 29.9x | 9.3% | US$39.7b |
ABBN ABB | 28.6x | 8.4% | CHF 92.6b |
WEGE3 WEG | 40.4x | 12.3% | R$233.6b |
EMR * Emerson Electric | 36.4x | 17.6% | Mex$62.3b |
Price-To-Earnings vs Peers: EMR * is expensive based on its Price-To-Earnings Ratio (36.4x) compared to the peer average (29.8x).
Price to Earnings Ratio vs Industry
How does EMR *'s PE Ratio compare vs other companies in the Global Electrical Industry?
Price-To-Earnings vs Industry: EMR * is expensive based on its Price-To-Earnings Ratio (36.4x) compared to the Global Electrical industry average (24.3x).
Price to Earnings Ratio vs Fair Ratio
What is EMR *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 36.4x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate EMR *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.